Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells
Andrew P. Fontenot, Laia Gharavi, Sean R. Bennett, Scott J. Canavera, Lee S. Newman, Brian L. Kotzin
Andrew P. Fontenot, Laia Gharavi, Sean R. Bennett, Scott J. Canavera, Lee S. Newman, Brian L. Kotzin
View: Text | PDF
Article Aging

CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells

  • Text
  • PDF
Abstract

T cell receptor engagement with CD28 costimulation is generally required for naive T cell activation, whereas reactivation of memory cells is less dependent on CD28 costimulation. We studied this process in chronic beryllium disease, in which the frequency of antigen-specific CD4+ T cells in the lung is large and circulating antigen-specific cells are also detectable. In the lung, a large fraction of CD4+ T cells stopped expressing CD28 mRNA and protein, and this change in phenotype correlated with lung inflammation. In the presence of concentrations of CTLA-4Ig that inhibited the CD28-B7 interaction, beryllium-specific CD4+ T cells in lung were still able to proliferate and secrete IFN-γ in response to beryllium in culture. This functional independence of CD28 costimulation included lung CD28+ effector cells. Although lung CD4+CD28– cells retained the ability to secrete Th1-type cytokines in response to beryllium, they showed less proliferative capacity and were more susceptible to cell death compared with CD28+ T cells. In contrast to lung cells, inhibition of the CD28-B7 interaction markedly reduced responses of beryllium-specific T cells in blood. Taken together, these findings suggest transition within memory CD4+ T cells from CD28 dependence in central memory cells to functional independence and then loss of CD28 expression in effector cells.

Authors

Andrew P. Fontenot, Laia Gharavi, Sean R. Bennett, Scott J. Canavera, Lee S. Newman, Brian L. Kotzin

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Proliferative responses of PBMCs (a) and BAL cells (b) from CBD patients...
Proliferative responses of PBMCs (a) and BAL cells (b) from CBD patients. Proliferation of the cells in medium alone and after the addition of BeSO4 with and without 30 μg/ml CTLA-4Ig is shown. The data are expressed as the mean counts per minute ± SEM. (c) Inhibition of the T cell proliferative responses of PBMCs and BAL cells to beryllium with various concentrations of CTLA-4Ig. PBMCs (n = 7) and BAL cells (n = 5) from CBD patients were cultured with 10–5 M BeSO4 and increasing concentrations of CTLA-4Ig. The data are expressed as the mean percentage inhibition of stimulation ± SEM as a function of the concentration of CTLA-4Ig.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts